Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery

The incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery has been evaluated in a study published in the latest edition of the journal Gut.

News image

fiogf49gjkf04

Professor G-Z Pan and colleagues from the Department of Gastroenterology at the Chinese Academy of Medical Sciences in Beijing, China, were interested to find out more about the pathogenesis of post-infective irritable bowel syndrome (IBS), about which little is known.

Therefore, they investigated the incidence of IBS and functional bowel disease (FBD) in a Chinese patient population who had recovered from bacillary dysentery.

They also examined the relationship between mast cells and intestinal nerves, as well as examining neuroimmunological changes in interleukins, mast cells and neuropeptides, in order to further understand its pathogenesis.

The researchers studied a cohort of 295 patient who had recovered from bacillary dysentery, 71.4% of whom had shigella identified from stool samples, as well as 243 control subjects. These consisted of patient siblings or spouses who had not been infected with bacillary dysentery.

Using questionnaires, all subjects were followed-up for 1 to 2 years in order to identify the incidence of FBD and IBS, as defined by the Rome II criteria.

Bacillary dysentery is a causative factor in post-infective IBS
Gut

In 56 cases of IBS, both post-infective and non post-infective, the numbers of mast cells in biopsy specimens from the intestinal mucosa were counted under light microscopy, following staining with anti-tryptase antibody.

In addition, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibers was observed using double staining with alcian blue and neuropeptide antibodies.

In 30 cases of IBS (half of which were post-infective), taken randomly from the 56 cases of IBS in total, expression of interleukin (IL)-1, IL-1ß, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction.

All the results were compared with 12 non-IBS controls.

The results showed that in the group of bacillary dysentery-infected patients, the incidences of FBD and IBS were 22.4% and 8.1%. In those who had provided stool samples positive for shigella, the incidence of IBS rose to 10.2%.

In the control group the levels of FBD and IBS were considerably lower, at 7.4% and 0.8% respectively.

The researchers found that a longer duration of diarrhea (7 days) was associated with a higher risk of developing FBD, while expression of IL-1ß mRNA in the terminal ileum and rectosigmoid mucosa was significantly higher in post-infective IBS patients.

The number of mast cells in the terminal ileum mucosa in post-infective IBS (11.19) and non-post-infective IBS patients (10.78) was significantly increased compared with that in control subjects (6.05).

Also, in the terminal ileum and rectosigmoid mucosa of IBS patients, the density of NSE, SP, and 5-HT positively stained nerve fibers increased and appeared in clusters, surrounding an increased number of mast cells compared with controls.

Commenting on their findings, Professor Pan said they showed that bacillary dysentery is a causative factor in post-infective IBS. He added that both the immune system and the nervous system may play important roles in the pathogenesis of post-infective IBS.

Gut 2004; 53 (8): 1096 - 1101
15 July 2004

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us